Table of Contents page: Journal of Thoracic Oncology

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

In This Issue/Research Watch/News-in-Brief/News from the IASLC Tobacco Control Committee

Published in issue: October 2018

p1425-1432

Recognizing the Challenges of Oncogene Fusion Detection: A Critical Step toward Optimal Selection of Lung Cancer Patients for Targeted Therapies

Lynette M. Sholl

Published in issue: October 2018

p1433-1435

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma

Dean A Fennell

Published in issue: October 2018

p1436-1437

$How Should We Treat Alectinib-Refractory ALK-Positive Non–Small Cell Lung Cancer?$

How Should We Treat Alectinib-Refractory ALK-Positive Non–Small Cell Lung Cancer?

Nagio Takigawa

Published in issue: October 2018

p1438-1440

Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy?

Rolando M. D’Angelillo,
Sara Ramella

Published in issue: October 2018

p1441-1442

Original Articles

Quality of Life

Lung Cancer Stigma across the Social Network: Patient and Caregiver Perspectives

Stefano Occhipinti,
Jeff Dunn,
Dianne L. O’Connell,
...
Kwun M. Fong,
Shalini Vinod,
Suzanne Chambers

Published online: July 05, 2018

p1443-1453

Screening/Epidemiology

Long-Term Active Surveillance of Screening Detected Subsolid Nodules is a Safe Strategy to Reduce Overtreatment

Mario Silva,
Mathias Prokop,
Colin Jacobs,
...
Carlotta Galeone,
Alfonso Marchianò,
Ugo Pastorino

Published online: July 16, 2018

p1454-1463

Outcomes Research

Racial Disparities in Lung Cancer Survival: The Contribution of Stage, Treatment, and Ancestry

Carissa C. Jones,
Sarah Fletcher Mercaldo,
Jeffrey D. Blume,
...
William J. Blot,
Eric L. Grogan,
Melinda C. Aldrich

Published online: June 06, 2018

p1464-1473

Translational Oncology

Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples

Kurtis D. Davies,
Anh T. Le,
Jamie Sheren,
...
Marileila Varella-Garcia,
Dara L. Aisner,
Robert C. Doebele

Published online: June 20, 2018

p1474-1482

Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer

Yanhong Liu,
Christine M. Lusk,
Michael H. Cho,
...
Ann G. Schwartz,
Christopher I. Amos,
Margaret R. Spitz

Published online: July 04, 2018

p1483-1495

Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naïve Lesions

Kenichi Suda,
Jihye Kim,
Isao Murakami,
...
Tetsuya Mitsudomi,
Aik-Choon Tan,
Fred R. Hirsch

Published online: June 19, 2018

p1496-1507

Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC

Nikhil Yegya-Raman,
Kyle Wang,
Sinae Kim,
...
Joseph Aisner,
Lawrence B. Marks,
Salma K. Jabbour

Published online: June 05, 2018

p1508-1518

Proteogenomic Analysis of Surgically Resected Lung Adenocarcinoma

Michael F. Sharpnack,
Nilini Ranbaduge,
Arunima Srivastava,
...
Kevin R. Coombes,
Kun Huang,
David P. Carbone

Published online: July 12, 2018

p1519-1529

Non–Small Cell Lung Cancer

$Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC$

Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC

Jessica J. Lin,
Viola W. Zhu,
Adam J. Schoenfeld,
...
Sai-Hong Ignatius Ou,
Alice T. Shaw,
Gregory J. Riely

Published online: June 20, 2018

p1530-1538

Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer

Yi-Long Wu,
Shun Lu,
You Lu,
...
Elizabeth T. Masters,
Paulina Selaru,
Tony S. Mok

Published online: July 02, 2018

p1539-1548

Histology, Tumor Volume, and Radiation Dose Predict Outcomes in NSCLC Patients After Stereotactic Ablative Radiotherapy

Kevin Shiue,
Alberto Cerra-Franco,
Ronald Shapiro,
...
Richard Zellars,
Feng-Ming Kong,
Tim Lautenschlaeger

Published online: June 26, 2018

p1549-1559

Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC

Jonathan W. Riess,
David R. Gandara,
Garrett M. Frampton,
...
Siraj M. Ali,
Philip C. Mack,
Alexa B. Schrock

Published online: July 05, 2018

p1560-1568

Mesothelioma

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma

Josine Quispel-Janssen,
Vincent van der Noort,
Jeltje F. de Vries,
...
Sjaak Burgers,
Wieneke Buikhuisen,
Paul Baas

Published online: June 13, 2018

p1569-1576

Trophoblast Glycoprotein is Associated With a Favorable Outcome for Mesothelioma and a Target for Antibody Drug Conjugates

Laurel M. Schunselaar,
Kim Monkhorst,
Vincent van der Noort,
...
Wilbert Zwart,
Jacques Neefjes,
Paul Baas

Published online: June 26, 2018

p1577-1587

Mismatch Repair Protein Defects and Microsatellite Instability in Malignant Pleural Mesothelioma

Surein Arulananda,
Bibhusal Thapa,
Marzena Walkiewicz,
...
David S. Williams,
Alexander Dobrovic,
Thomas John

Published online: July 26, 2018

p1588-1594

Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET–Rearranged Lung Cancers

Alexander Drilon,
Jessica J. Lin,
Thomas Filleron,
...
Julien Mazieres,
Justin F. Gainor,
Oliver Gautschi

Published online: July 12, 2018

p1595-1601

Carcinoid Heart Disease in Patients With Bronchopulmonary Carcinoid

Tais De Jesus,
S. Allen Luis,
Jay H. Ryu,
...
Heidi M. Connolly,
Joseph J. Maleszewski,
Patricia A. Pellikka

Published online: July 06, 2018

p1602-1605

Vogt-Koyanagi-Harada Syndrome Induced by Pembrolizumab in a Patient with Non–Small Cell Lung Cancer

Tomoki Tamura,
Etsuko Akimoto,
Chiaki Matsumoto,
...
Tatuya Nishi,
Kennichiro Kudo,
Syouichi Kuyama

Published online: May 03, 2018

p1606-1607

Clinical Outcome and Molecular Analysis of a Chinese Patient With Lung Adenocarcinoma Harboring Rare EGFR Mutation V834L

Juan Li,
Lei Zhang,
Yan Wu,
Wanning Yang,
Zhenzhou Yang,
Henghui Zhang

Published online: April 26, 2018

e189-e191

CD103+CD8+ Lymphocytes Characterize the Immune Infiltration in a Case With Pseudoprogression in Squamous NSCLC

Pedro Rocha,
Max Hardy-Werbin,
Dolores Naranjo,
...
Oliver Wood,
Christian H. Ottensmeier,
Edurne Arriola

Published online: May 15, 2018

e193-e196

A Case of Primary Pulmonary Combined Small Cell Carcinoma With Adenocarcinoma Harboring the Same KLC1-ALK Fusion in Both Histologic Components

Qianming Bai,
Yuan Li,

Xin Zhang,

Xiaoli Zhu,
Xiaoyan Zhou

Published in issue: October 2018

e197-e199

Favorable Outcome With Pemetrexed Treatment for Advanced BRAF-V600E-Positive Lung Adenocarcinoma in a Patient Followed up Over 8 Years

Yoko Nakanishi,

Yoshiko Nakagawa,
Ichiro Tsujino,
Tetsuo Shimizu,
Noriaki Takahashi,
Shu Hashimoto,

Shinobu Masuda

Published in issue: October 2018

e199-e202

MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma

You-cai Zhu,

Wen-xian Wang,
Zheng-bo Song,

Qu-xia Zhang,
Chun-wei Xu,
Gang Chen,

Wu Zhuang,

Tangfeng Lv,
Yong Song

Published in issue: October 2018

e202-e204

Response to Osimertinib in an EGFR Exon 20 Insertion-Positive Lung Adenocarcinoma

Zofia Piotrowska,

Florian J. Fintelmann,

Lecia V. Sequist,

Balkrishna Jahagirdar

Published in issue: October 2018

e204-e206

Gefitinib-Induced Cardiomyopathy in Epidermal Growth Receptor-Mutated NSCLC

Shota Omori,

Takuya Oyakawa,

Tateaki Naito,
Toshiaki Takahashi

Published in issue: October 2018

e207-e208

Pseudoprogression and Rapid Response to Pembrolizumab in a Patient with Advanced Lung Adenocarcinoma with Loss of Epidermal Growth Factor Receptor Gene Mutation after Tyrosine Kinase Inhibitor Therapy

Takumi Yamaura,
Hiroyuki Suzuki

Published in issue: October 2018

e209-e210

A Case of Small Cell Lung Cancer Transformation from EGFR-Mutant Lung Adenocarcinoma with Primary Resistance to Gefitinib

Xiao Chu,

Yuan Li,

Zhengfei Zhu

Published in issue: October 2018

e211-e214

Editorial Board

Published in issue: October 2018

A1-A2

Board of Directors

Published in issue: October 2018

A5

Meeting Announcements

Published in issue: October 2018

A6

October 2018

Editorials

Original Articles

Quality of Life

Screening/Epidemiology

Outcomes Research

Translational Oncology

Non–Small Cell Lung Cancer

Mesothelioma

Brief Reports

Image of the Month

Case Reports

Letters to the Editor

Frontmatter